As of December 2024, Sonnet BioTherapeutics Holdings has a market cap of $1.79M. This makes Sonnet BioTherapeutics Holdings the world's 5556th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.66M | -8.05% |
2023 | $1.81M | 51.30% |
2022 | $1.19M | -79.97% |
2021 | $5.96M | -81.61% |
2020 | $32.41M | -85.46% |
2019 | $222.96M | -54.26% |
2018 | $487.49M | -50.95% |
2017 | $993.88M | -37.38% |
2016 | $1.59B | -58.00% |
2015 | $3.78B | -42.20% |
2014 | $6.54B | -67.78% |
2013 | $20.29B | 47.53% |
2012 | $13.76B | -50.81% |
2011 | $27.96B | 74.12% |
2010 | $16.06B | 6.25% |
2009 | $15.12B | -30.43% |
2008 | $21.73B | 10.58% |
2007 | $19.65B | -52.73% |
2006 | $41.57B | - |